Abstract
Aim To estimate the COVID-19 infection-to-fatality ratio (IFR), infection-to-case ratio (ICR), and infection-to-ICU admission ratio (IIAR) in Sweden; to suggest methods for time series reconstruction and prediction.
Methods We optimize a set of simple finite impulse response (FIR) models comprising of a scaling factor and time-delay between officially reported cases, ICU admissions and deaths time series using the least squares method. Combined with randomized PCR study results, we utilize this simple model to estimate the total number of infections in Sweden, and the corresponding IFR.
Results The model class provides a good fit between ICU admissions and deaths throughout 2020. Cases fit consistently from July 2020, by when PCR tests had become broadly available. We observe a diminished IFR in late summer as well as a strong decline during 2021, following the launch of a nation-wide vaccination program. The total number of infections during 2020 is estimated to 1.3 million.
Conclusions A FIR model with a delta filter function describes the evolution of epidemiological data in Sweden well. The fact that we found IFR, ICR and IIAR constant over large parts of 2020 is in contrast with claims of healthcare adaptation or mutated virus variants importantly affecting these ratios. The model allows us to retrospectively estimate the COVID-19 epidemiological trajectory, and conclude that Sweden was far from herd immunity by the end of 2020.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was partially funded by the ELLIIT Strategic Research Area.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Only publicly available data sets have been used. They are referenced in the manuscript.
Nomenclature
- Acronyms
- FIR
- Finite impulse response [model]
- ICR
- Infection-to-case ratio
- ICU
- Intensive care unit
- IFR
- Infection-to-fatality ratio
- IIAR
- Infection-to-ICU admission ratio
- LS
- Least-squares [method]
- PCR
- Polymerace chain reaction
- Subscripts and modifiers
- a
- Infection-to-ICU admission
- c
- Case (detected infection)
- d
- Infection-to-fatality (death)
- ∼
- Weekly central moving average
- Variables and symbols
- δ
- Dirac’s delta distribution
- γ
- IIAR/ICR
- σ
- Standard deviation
- τ
- Time delay (unit:days)
- b
- Gain parameter
- e
- Error or residual time series
- N
- Number of individuals
- p
- Probability
- t
- Time index (unit:days)
- x
- New infection time series (not directly observable)
- y
- Daily time series (observation)
